<?xml version="1.0" encoding="UTF-8"?>
<p id="para470">The 2020 COVID-19 pandemic shows no signs of abating, with WHO reporting 4·9 million cases and 322 000 deaths globally as of May 21, 2020. What also shows no sign of abating is the ferocious reactive response to the pandemic—academic institutions, pharmaceutical companies, and governments alike have turned almost their whole focus to COVID-19 research, causing many health-care experts to fear that the management of other deadly diseases has been relegated to a much lower priority. The intense focus on COVID-19 might hinder the efforts and undo progress made in controlling other infectious diseases. Thousands of people died during Liberia's 2014–16 Ebola virus crisis from other preventable diseases because they were unable to get care, and a similar scenario might result from the COVID-19 pandemic. Madhukar Pai (McGill International TB Centre, Montreal, QC, Canada) is worried about what he terms as the “covidisation” of everything, highlighting how a narrow framework that focuses solely on health crises can be harmful to other areas of health and health-care agendas. “We are already seeing massive setbacks to tuberculosis, AIDS, and malaria care in many settings, because all the attention and resources are diverted to COVID-19”, he told 
 <italic>The Lancet Microbe</italic>.
</p>
